Literature DB >> 30361535

Entamoeba histolytica-induced IL-1β secretion is dependent on caspase-4 and gasdermin D.

Jeanie Quach1, France Moreau1, Christina Sandall1, Kris Chadee2.   

Abstract

During invasion, Entamoeba histolytica (Eh) encounter macrophages and activate them to elicit tissue damaging pro-inflammatory responses. When Eh binds macrophages via the Gal-lectin, surface EhCP-A5 RGD sequence ligates α5β1 integrin to activate caspase-1 in a complex known as the NLRP3 inflammasome. In this study, we investigated Eh requirements underlying macrophage caspase-4 and -1 activation and the role caspase-4 and gasdermin D (GSDMD) play in augmenting pro-inflammatory cytokine responses. Caspase-4 activation was similar to caspase-1 requiring live Eh attachment via the Gal-lectin and EhCP-A5. However, unlike caspase-1, caspase-4 activation was independent of ASC and NLRP3. Using CRISPR/Cas9 gene editing of caspase-4 and -1 and GSDMD, we determined that caspase-1 and bioactive IL-1β release was highly dependent on caspase-4 activation and cleavage of GSDMD in response to Eh. Formaldehyde cross-linking to stabilize protein-protein interactions in transfected COS-7 cells stimulated with Eh revealed that caspase-4 specifically interacted with caspase-1 in a protein complex that enhanced the cleavage of caspase-1 CARD domains to augment IL-1β release. Activated caspase-4 and -1 cleaved GSDMD liberating the N-terminal p30 pore-forming fragment that caused the secretion of IL-1β. These findings reveal a novel role for caspase-4 as a sensor molecule to amplify pro-inflammatory responses when macrophage encounters Eh.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30361535     DOI: 10.1038/s41385-018-0101-9

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  3 in total

1.  Adherence of Entamoeba histolytica trophozoites to rat and human colonic mucosa.

Authors:  J I Ravdin; J E John; L I Johnston; D J Innes; R L Guerrant
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

2.  Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

3.  Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine.

Authors:  J Y Lin; K Chadee
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

  3 in total
  6 in total

Review 1.  Signaling Role of NADPH Oxidases in ROS-Dependent Host Cell Death Induced by Pathogenic Entamoeba histolytica.

Authors:  Young Ah Lee; Seobo Sim; Kyeong Ah Kim; Myeong Heon Shin
Journal:  Korean J Parasitol       Date:  2022-06-30       Impact factor: 1.776

2.  Entamoeba histolytica exploits the autophagy pathway in macrophages to trigger inflammation in disease pathogenesis.

Authors:  Sharmin Begum; France Moreau; Antoine Dufour; Kris Chadee
Journal:  Mucosal Immunol       Date:  2021-05-07       Impact factor: 7.313

3.  A Novel TLR4-Binding Domain of Peroxiredoxin From Entamoeba histolytica Triggers NLRP3 Inflammasome Activation in Macrophages.

Authors:  Xia Li; Meng Feng; Yanqing Zhao; Yuhan Zhang; Ruixue Zhou; Hang Zhou; Zhen Pang; Hiroshi Tachibana; Xunjia Cheng
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

4.  The colonic pathogen Entamoeba histolytica activates caspase-4/1 that cleaves the pore-forming protein gasdermin D to regulate IL-1β secretion.

Authors:  Shanshan Wang; France Moreau; Kris Chadee
Journal:  PLoS Pathog       Date:  2022-03-18       Impact factor: 6.823

Review 5.  Gasdermins in Innate Host Defense Against Entamoeba histolytica and Other Protozoan Parasites.

Authors:  Shanshan Wang; France Moreau; Kris Chadee
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 6.  Channelling inflammation: gasdermins in physiology and disease.

Authors:  Xing Liu; Shiyu Xia; Zhibin Zhang; Hao Wu; Judy Lieberman
Journal:  Nat Rev Drug Discov       Date:  2021-03-10       Impact factor: 112.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.